370 related articles for article (PubMed ID: 16013717)
21. Dosimetric characterization of a 131Cs brachytherapy source by thermoluminescence dosimetry in liquid water.
Tailor R; Ibbott G; Lampe S; Warren WB; Tolani N
Med Phys; 2008 Dec; 35(12):5861-8. PubMed ID: 19175142
[TBL] [Abstract][Full Text] [Related]
22. Monte Carlo dosimetry of a new 192Ir pulsed dose rate brachytherapy source.
Karaiskos P; Angelopoulos A; Pantelis E; Papagiannis P; Sakelliou L; Kouwenhoven E; Baltas D
Med Phys; 2003 Jan; 30(1):9-16. PubMed ID: 12557972
[TBL] [Abstract][Full Text] [Related]
23. Determination of task group 43 dosimetric parameters for CSM40
Firoozabadi MM; Jimabadi E; Ghorbani M; Behmadi M
Radiol Phys Technol; 2018 Mar; 11(1):82-90. PubMed ID: 29299819
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric characteristics of a new 125I brachytherapy source.
Gearheart DM; Drogin A; Sowards K; Meigooni AS; Ibbott GS
Med Phys; 2000 Oct; 27(10):2278-85. PubMed ID: 11099194
[TBL] [Abstract][Full Text] [Related]
25. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
26. Calculated dosimetric parameters of the IoGold 125I source model 3631-A.
Wierzbicki JG; Rivard MJ; Waid DS; Arterbery VE
Med Phys; 1998 Nov; 25(11):2197-9. PubMed ID: 9829245
[TBL] [Abstract][Full Text] [Related]
27. Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds.
Rodriguez M; Rogers DW
Med Phys; 2014 Nov; 41(11):114301. PubMed ID: 25370677
[TBL] [Abstract][Full Text] [Related]
28. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
Moutsatsos A; Pantelis E; Papagiannis P; Baltas D
Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795
[TBL] [Abstract][Full Text] [Related]
29. Thermoluminescent dosimetry of the selectseed 125I interstitial brachytherapy seed.
Anagnostopoulos G; Baltas D; Karaiskos P; Sandilos P; Papagiannis P; Sakelliou L
Med Phys; 2002 May; 29(5):709-16. PubMed ID: 12033566
[TBL] [Abstract][Full Text] [Related]
30. Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed.
Patel NS; Chiu-Tsao ST; Williamson JF; Fan P; Duckworth T; Shasha D; Harrison LB
Med Phys; 2001 Aug; 28(8):1761-9. PubMed ID: 11548947
[TBL] [Abstract][Full Text] [Related]
31. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
32. Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source.
Meigooni AS; Dini SA; Sowards K; Hayes JL; Al-Otoom A
Med Phys; 2002 Jun; 29(6):939-42. PubMed ID: 12094988
[TBL] [Abstract][Full Text] [Related]
33. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of TG-43 recommended 2D-anisotropy function for elongated brachytherapy sources.
Awan SB; Meigooni AS; Mokhberiosgouei R; Hussain M
Med Phys; 2006 Nov; 33(11):4271-9. PubMed ID: 17153405
[TBL] [Abstract][Full Text] [Related]
35. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
Duggan DM
Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
[TBL] [Abstract][Full Text] [Related]
36. Validation of GPUMCD for low-energy brachytherapy seed dosimetry.
Hissoiny S; Ozell B; Després P; Carrier JF
Med Phys; 2011 Jul; 38(7):4101-7. PubMed ID: 21859010
[TBL] [Abstract][Full Text] [Related]
37. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
[TBL] [Abstract][Full Text] [Related]
38. Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry.
Chen Z; Bongiorni P; Nath R
Med Phys; 2005 Nov; 32(11):3279-85. PubMed ID: 16372409
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a new brachytherapy iodine-125 source by AAPM TG43 formalism.
Wallace RE; Fan JJ
Med Phys; 1998 Nov; 25(11):2190-6. PubMed ID: 9829244
[TBL] [Abstract][Full Text] [Related]
40. Dosimetry of the I-Plant Model 3500 iodine-125 brachytherapy source.
Duggan DM; Johnson BL
Med Phys; 2001 Apr; 28(4):661-70. PubMed ID: 11339764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
